DOXORUBICIN CLEARANCE IN THE OBESE

被引：169

作者：

RODVOLD, KA

RUSHING, DA

TEWKSBURY, DA

机构：

[1] UNIV ILLINOIS,COLL PHARM,CLIN PHARMACOKINET LAB,CHICAGO,IL 60612

[2] MARSHFIELD CLIN,DEPT MED ONCOL,MARSHFIELD,WI 54449

[3] MARSHFIELD MED FDN INC,MARSHFIELD,WI 54449

来源：

关键词：

D O I：

10.1200/JCO.1988.6.8.1321

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1321 / 1327

页数：7

共 32 条

[11]

BRENNER DE, 1984, CANCER, V53, P1042, DOI 10.1002/1097-0142(19840301)53:5<1042::AID-CNCR2820530505>3.0.CO

[12]

2-B

[13]

BRENNER DE, 1986, CANCER CHEMOTH PHARM, V18, P219

[14]

CHAN KK, 1978, CANCER TREAT REP, V62, P1161

[15]

CHAN KK, 1980, CANCER RES, V40, P1263

[16]

CHLEBOWSKI RT, 1984, CANCER TREAT REP, V68, P487

[17]

CROM WR, 1986, TXB CLIN APPLICATION, P421

[18]

DuBois D, 1915, ARCH INTERN MED, V15, P868

[19]

FRESTON JW, 1967, CLIN SCI, V33, P301

[20]

GAL P, 1978, CLIN PHARMACOL THER, V23, P438